This content is machine translated Fungal infections of the lungs Three approaches to reduce P. jirovecii mortality Pneumocystis jirovecii pneumonia (PcP) is associated with a high mortality rate, but the influence of an immunocompromised underlying disease on the clinical presentation, severity and mortality of PcP has not…
View Post 10 min This content is machine translated Options in the relapse therapy of multiple myeloma. What comes after the first line? Factors such as pretreatment, age, patient performance, and comorbidities determine relapse therapy in multiple myeloma. Triple combinations with a proteasome inhibitor and/or an IMID are standard. Antibody therapies also play…
View Post 4 min This content is machine translated Multiple Myeloma Active ingredients at a glance At the EHA Congress in Milan, multiple myeloma was the focus of several events. What are the current results of proteasome inhibitors and immunomodulatory drugs and what is their promise…
